therapeutic target

You have access
PAR1 Is a Candidate Target for the Treatment of Peritoneal Dissemination in Gastric Cancer
DAISUKE FUJIMOTO and HIROTOSHI KOBAYASHI

Anticancer Research November 2024, 44 (11) 4857-4867; DOI: https://doi.org/10.21873/anticanres.17311
Open Access
Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target
HIROTAKA SUTO

Anticancer Research October 2024, 44 (10) 4147-4153; DOI: https://doi.org/10.21873/anticanres.17245
Open Access
Tropomyosin-related Kinase B Is Potentially a Biomarker of Prognosis and Therapeutic Target for Malignant Thymic Epithelial Tumors
KEIGO OZONO, HIDEYA ONISHI, NAOYA IWAMOTO, KATSUYA NAKAMURA, KEI MIYOSHI, MASAFUMI NAKAMURA and YOSHINAO ODA

Anticancer Research August 2022, 42 (8) 3779-3787; DOI: https://doi.org/10.21873/anticanres.15868
You have access
BAF57 Is a Potential Determinant of Colorectal Cancer Malignancy
HIROFUMI SUZUMURA, MASASHI TSURUTA, KOJI OKABAYASHI, KOHEI SHIGETA, RYO SEISHIMA, TAKASHI ISHIDA, TAKEHIRO SHIMADA, YUSUKE ASADA, KAORU KOISHIKAWA, SHINGO AKIMOTO, OSAMU ITANO, HIROTOSHI HASEGAWA and YUKO KITAGAWA

Anticancer Research November 2021, 41 (11) 5445-5452; DOI: https://doi.org/10.21873/anticanres.15356
You have access
TACC3 Promotes Gastric Carcinogenesis by Promoting Epithelial-mesenchymal Transition Through the ERK/Akt/cyclin D1 Signaling Pathway
MD RASHEDUNNABI AKANDA, JEE SOO PARK, MYUNG-GIUN NOH, GEUN-HYOUNG HA, YOUNG SOOK PARK, JAE-HYUK LEE, KYUNG-SUB MOON, CHUNG KWON KIM and KYUNG-HWA LEE

Anticancer Research July 2021, 41 (7) 3349-3361; DOI: https://doi.org/10.21873/anticanres.15123
You have access
Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression
SO-YOUNG PARK, YU-RI SEO, MIN JI KO, JAE-HO LEE, KYUNG-SOO CHUN, MIN-JI KIM, YOUNG-KUG CHOO, TAE-JIN LEE and YUN-HAN LEE

Anticancer Research March 2021, 41 (3) 1315-1325; DOI: https://doi.org/10.21873/anticanres.14889
You have access
RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer
HIDEYA ONISHI, SHU ICHIMIYA, KOSUKE YANAI, MASAYO UMEBAYASHI, KATSUYA NAKAMURA, AKIO YAMASAKI, AKIRA IMAIZUMI, SHUNTARO NAGAI, MUTSUNORI MURAHASHI, HISANOBU OGATA and TAKASHI MORISAKI

Anticancer Research August 2018, 38 (8) 4543-4547; DOI: https://doi.org/10.21873/anticanres.12758
You have access
Silencing lnc-ASAH2B-2 Inhibits Breast Cancer Cell Growth via the mTOR Pathway
JINGJING LI, JING ZHANG, LIANG JIN, HERAN DENG and JIANNAN WU

Anticancer Research June 2018, 38 (6) 3427-3434; DOI: https://doi.org/10.21873/anticanres.12611
You have access
NOTCH4 Is a Potential Therapeutic Target for Triple-negative Breast Cancer
IORI NAGAMATSU, HIDEYA ONISHI, SHOJIRO MATSUSHITA, MAKOTO KUBO, MASAYA KAI, AKIRA IMAIZUMI, KENJI NAKANO, MASAMI HATTORI, YOSHINAO ODA, MASAO TANAKA and MITSUO KATANO

Anticancer Research January 2014, 34 (1) 69-80;

Main menu

User menu

Search

therapeutic target